Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Voyageur Pharmaceuticals Signs Letter of Intent with Multinational Pharmaceutical Company and Secures Sales Contract in Latin America

Jan 24, 2025•over 1 year ago

Contract Type

partnership

Sao PauloManufacturingBiotechnologyPharmaceutical

Description

Voyageur Pharmaceuticals has made significant strides by signing a Letter of Intent with a multinational pharmaceutical company, which holds the potential to bring credibility and financial backing to Voyageur as the demand for radiology drugs increases. Additionally, the company has secured its first sales contract in Latin America for one of their Health Canada licensed products, marking an important step towards their plans for international expansion.

Company Information

Company

Voyageur Pharmaceuticals

Location

Sao Paulo, Sao Paulo, Brazil

About

Voyageur is a Canadian public company trading under the symbol VM on the TSXV. The company is in development of barium and iodine Active Pharmaceutical Ingredients (API) and intends to offer high-performance, cost-effective imaging contrast agents.

Predictive Intelligence
Strategic

ML-powered predictions for Voyageur Pharmaceuticals's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.